Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.
about
Current and emerging azole antifungal agentsMultiple efflux mechanisms are involved in Candida albicans fluconazole resistancePotential use of BacT/Alert automated blood culture system for antifungal susceptibility testing.Estimation of minimum sterol 14alpha-demethylation-inhibitory concentration of azoles in Candida yeasts using acetate-mediated growth inhibition: potential utility in susceptibility testingCHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growthModified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compoundsIsolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypesIn vitro and in vivo activities of the novel azole antifungal agent r126638.Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence.Effects of temperature on anti-Candida activities of antifungal antibiotics.Oxygen as limiting nutrient for growth of Cryptococcus neoformans.Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis.Detection of Candida albicans and other yeasts in blood by PCRAcetate-mediated growth inhibition in sterol 14alpha-demethylation-deficient cells of Candida albicans.Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.Antifungal susceptibility testingPrior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study.Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group.Identification of Candida albicans clinical isolates by PCR amplification of an EFB1 gene fragment containing an intron-interrupted open reading frame.Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay.Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans.Identification of pathogenic yeast species by polymerase chain reaction amplification of the RPS0 gene intron fragment.
P2860
Q24550733-B5A1A466-F805-4035-B42E-686A4957CA2BQ28379619-BB4081AD-442E-4835-9685-637A2CE880BCQ30451507-301C11E0-A05A-48E1-BC3B-573A2B773AB1Q33968775-24C74EEF-A67D-4180-B879-0FA48C1E64DEQ34327523-88780B76-BBFF-4AA6-91BD-E96225FD0E7DQ35118435-901D1E35-F505-40B8-9A73-00D9DEF38425Q35122897-14C47763-58B6-4955-8CB6-190EB01CDA04Q35136757-E2DEA8E2-CDB2-47F1-AB9B-83F504035F80Q35137446-54CAC37E-9D6B-4C62-A5AF-15570DE2CB8CQ35548093-D127690A-BDA7-4810-B0D9-7F080541CB6EQ35554184-B0D8064C-A29C-41D1-8C6C-CA3FE535EA76Q35554209-65AE1866-0575-44CC-BF40-FAB3E69623BEQ35811074-332D4F04-7D7D-4C86-9EE8-DCC1BEF0CDA6Q36521041-47B40665-7709-4AA4-92B0-D7E761C7BA53Q36543546-D4FAA084-0437-43F2-AE73-E7A79A7B9712Q37070463-240FE854-408C-4667-9DFF-F0438B033FECQ39469558-3F174E8C-2AAA-4AF9-8D6B-0814F4D28E44Q39569437-B951167B-7CCC-4D05-B51F-04EC750A373CQ39867423-D389ECD7-48E9-4A85-A3EC-C9287B9B5CC2Q40795131-FE743624-9CFC-4D92-9220-39C9F219C962Q41930821-722F3C49-CB18-47F6-98C5-0C2A6CDD4980Q43473551-3775CEFF-778C-4CD9-BD16-948847D52E6DQ46148949-0EE6396A-5128-46AE-9F6D-E5658F7FC57FQ53009861-4478320F-D2A4-4712-A219-E666238EBE22Q54033174-97C637FC-1FD0-4480-8F07-B43D0E57F347Q54451304-1B0D2114-68A0-4CC2-BF6E-743A8EAEA40E
P2860
Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Antifungal susceptibility test ...... trations of antifungal agents.
@en
Antifungal susceptibility test ...... trations of antifungal agents.
@nl
type
label
Antifungal susceptibility test ...... trations of antifungal agents.
@en
Antifungal susceptibility test ...... trations of antifungal agents.
@nl
prefLabel
Antifungal susceptibility test ...... trations of antifungal agents.
@en
Antifungal susceptibility test ...... trations of antifungal agents.
@nl
P2860
P356
P1476
Antifungal susceptibility test ...... trations of antifungal agents.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.8.1727
P407
P577
1992-08-01T00:00:00Z